General
South Africa to suspend rollout of AstraZeneca coronavirus vaccine
South Africa was set to suspend the rollout of the AstraZeneca vaccine after trial data showed the jab offered limited protection against mild disease caused by B.1.351, the coronavirus variant first identified in the country.
Key points:
- Early data from an Oxford University study suggested the AstraZeneca vaccine offered only “minimal protection” against the South Africa variant
- Vaccine lead researcher Sarah Gilbert said the company expected to have a new jab to cope with the variant by September
- Federal Health Minister Greg Hunt said he was not concerned about vaccine
Early data from an Oxford University study suggested the AstraZeneca vaccine offered only “minimal protection” against mild disease caused by the South Africa variant.
But the…
Continue Reading
-
General13 hours agoMelbourne lawyer fled Australia with $1.2m after filing for bankruptcy, court case alleges
-
General24 hours agoInjured former Greens candidate Hannah Thomas charged with hindering or resisting police at pro-Palestinian protest
-
General23 hours agoTony Burke’s detention inaction | The Spectator Australia
-
Noosa News15 hours agoWounding investigation, Mooloolaba – Sunshine Coast